Certificate u/r 74(5) for the quarter ended March 31, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Samrat Pharmachem has submitted to BSE a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2025. The certificate was issued by the company's Registrar and Transfer Agent (RTA), MUFG Intime India Pvt. Ltd. It confirms that all physical share certificates received from shareholders for dematerialisation during the quarter were properly processed, confirmed or rejected by the depositories, and that the cancelled certificates were mutilated after due verification. The RTA also confirms that the names of depositories have been substituted as the registered owners in the company's register of members within the prescribed timelines.
No material impact on shareholders or the stock price. This is a routine quarterly compliance filing that confirms the proper handling of share dematerialisation requests, with no change to business operations, financials, or shareholding structure.